KEYNOTE-024 5-year OS update: First-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumour proportion score (TPS) ≥50%

被引：74

作者：

Brahmer, J. R. ^{[1
]}

Rodriguez-Abreu, D. ^{[2
]}

Robinson, A. G. ^{[3
,4
]}

Hui, R. ^{[3
,4
]}

Csoszi, T. ^{[5
]}

Fulop, A. ^{[6
]}

Gottfried, M. ^{[7
]}

Peled, N. ^{[8
]}

Tafreshi, A. ^{[9
,10
]}

Cuffe, S. ^{[11
,12
]}

O'Brien, M. ^{[13
]}

Rao, S. ^{[14
]}

Hotta, K. ^{[15
]}

Leal, T. A. ^{[16
]}

Riess, J. W. ^{[17
]}

Jensen, E. ^{[18
]}

Zhao, B. ^{[18
]}

Pietanza, M. C. ^{[18
]}

Reck, M. ^{[19
]}

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Oncol, Baltimore, MD USA

[2] Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain

[3] Westmead Hosp, Med Oncol, Sydney, NSW, Australia

[4] Univ Sydney, Sydney, NSW, Australia

[5] Jasz Nagykun Szolnok Cty Hosp, Oncol, Szolnok, Hungary

[6] Orszagos Koranyi Pulmonol Intezet, Med Oncol, Budapest, Hungary

[7] Meir Med Ctr, Med Oncol, Kefar Sava, Israel

[8] Soroka Univ Med Ctr, Ctr Canc, Beer Sheva, Israel

[9] Wollongong Private Hosp, Med Oncol, Wollongong, NSW, Australia

[10] Univ Wollongong, Wollongong, NSW, Australia

[11] St James Hosp, Med Oncol, Dublin, Ireland

[12] Canc Trials Ireland, Dublin, Ireland

[13] Royal Marsden Hosp, Med Oncol, Sutton, Surrey, England

[14] MedStar Franklin Sq Hosp, Med Oncol, Baltimore, MD USA

[15] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan

[16] Univ Wisconsin, Carbone Canc Ctr, Div Hematol & Oncol, Madison, WI USA

[17] UC Davis Comprehens Canc Ctr, Div Hematol Oncol, Sacramento, CA USA

[18] Merck & Co Inc, Oncol, Kenilworth, NJ USA

[19] German Ctr Lung Res, Airway Res Ctr North, Lungen Clin, Grosshansdorf, Germany

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.2284

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA51

引用

页码：S1181 / S1182

页数：2